KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Non-Current Debt (2022 - 2025)

Opko Health's Non-Current Debt history spans 4 years, with the latest figure at $246.4 million for Q4 2025.

  • For Q4 2025, Non-Current Debt changed 0.35% year-over-year to $246.4 million; the TTM value through Dec 2025 reached $246.4 million, changed 0.35%, while the annual FY2025 figure was $246.4 million, 0.35% changed from the prior year.
  • Non-Current Debt reached $246.4 million in Q4 2025 per OPK's latest filing, up from $2.5 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $246.4 million in Q4 2025 to a low of $2.5 million in Q3 2025.
  • Average Non-Current Debt over 4 years is $85.8 million, with a median of $8.2 million recorded in 2023.
  • The largest YoY upside for Non-Current Debt was 6592.38% in 2025 against a maximum downside of 98.98% in 2025.
  • A 4-year view of Non-Current Debt shows it stood at $9.1 million in 2022, then fell by 15.27% to $7.7 million in 2023, then soared by 3085.58% to $245.6 million in 2024, then grew by 0.35% to $246.4 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Non-Current Debt are $246.4 million (Q4 2025), $2.5 million (Q3 2025), and $246.0 million (Q2 2025).